Abstract
This Practice Point commentary discusses a study by Kato et al. that assessed the usefulness of three PET tracers— 11C-methionine (MET), 18F-fluorodeoxyglucose, and 11C-choline—for the metabolic evaluation of gliomas. The authors measured the ratio of tumor uptake to normal brain uptake (T/N ratio), with the frontal cortex as reference region, and analyzed the correlations between tracer uptake and tumor grade, type, and proliferation activity. Whereas all three tracers showed a similar correlation between the T/N ratio and tumor grade in astrocytic and oligodendroglial tumors, MET proved to be the most user-friendly marker in all gliomas as it enables the straightforward localization of 'hot lesions' and provides outstanding quantitative metabolic parameters. Here we highlight a few methodological issues arising from Kato et al.'s study and, consequently, we urge the PET community to reach a consensus on an objective approach towards the evaluation of PET tracers in the field of neuro-oncology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Warburg O et al. (1924) Über den Stoffwechsel der Tumoren [German]. Biochemische Zeitschrift 152: 319–344. Reprinted in English in The Metabolism of Tumours by O Warburg (1930) London: Constable
Herholz K et al. (2007) Metabolic and molecular imaging in neuro-oncology. Lancet Neurol 6: 711–724
Pirotte B et al. (2004) Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg 101: 476–483
Borbély K et al. (2006) Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 246: 85–94
Kato T et al. (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29: 1176–1182
Tian M et al. (2004) Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 31: 1064–1072
Narayanan TK et al. (2002) A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma. Mol Imaging Biol 4: 147–156
Di Chiro G et al. (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gulyás, B., Nyáry, I. & Borbély, K. FDG, MET or CHO? The quest for the optimal PET tracer for glioma imaging continues. Nat Rev Neurol 4, 470–471 (2008). https://doi.org/10.1038/ncpneuro0863
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0863
This article is cited by
-
Molecular imaging of brain tumors with radiolabeled choline PET
Neurosurgical Review (2018)
-
Non-invasive metabolic imaging of brain tumours in the era of precision medicine
Nature Reviews Clinical Oncology (2016)
-
Value of 11C-methionine PET in imaging brain tumours and metastases
European Journal of Nuclear Medicine and Molecular Imaging (2013)